{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:39:44Z","timestamp":1793630384619,"version":"4.5.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.josat.2024.209601","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T07:30:40Z","timestamp":1733988640000},"page":"209601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pharmacological treatments for co-occurring PTSD and substance use disorders: A systematic review"],"prefix":"10.1016","volume":"169","author":[{"given":"Megan","family":"Swannell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.J.","family":"Bradlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Manahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Arunogiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2024.209601_bb0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.neuropharm.2011.04.029","article-title":"Hippocampal dysfunction effects on context memory: Possible etiology for posttraumatic stress disorder","volume":"62","author":"Acheson","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1345\/aph.1L578","article-title":"Topiramate in combat-related posttraumatic stress disorder","volume":"43","author":"Alderman","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.josat.2024.209601_bb0015","doi-asserted-by":"crossref","first-page":"188ra73","DOI":"10.1126\/scitranslmed.3005656","article-title":"Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD","volume":"5","author":"Andero","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.josat.2024.209601_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","article-title":"Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review","volume":"61","author":"Ann Priester","year":"2016","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2024.209601_bb0025","author":"APA"},{"key":"10.1016\/j.josat.2024.209601_bb0030","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.biopsych.2011.01.027","article-title":"Catecholamine influences on dorsolateral prefrontal cortical networks","volume":"69","author":"Arnsten","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0035","series-title":"Long-term outcomes of prolonged exposure and naltrexone for patients with comorbid posttraumatic stress disorder and alcohol dependence","author":"Avny","year":"2014"},{"key":"10.1016\/j.josat.2024.209601_bb0040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.nmd.0000235794.12794.8a","article-title":"Symptom improvement in co-occurring PTSD and alcohol dependence","volume":"194","author":"Back","year":"2006","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.josat.2024.209601_bb0045","article-title":"A double-blind randomized controlled trial of doxazosin for co-occurring PTSD and alcohol use disorder in veterans","volume":"8;84(2)","author":"Back","year":"2023","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0050","doi-asserted-by":"crossref","first-page":"e1439","DOI":"10.4088\/JCP.15m10239","article-title":"A double-blind, randomized, controlled pilot trial of N-acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders","volume":"77","author":"Back","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1300.023","article-title":"N-acetyl cysteine-induced blockade of cocaine-induced reinstatement","volume":"1003","author":"Baker","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.josat.2024.209601_bb0065","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.drugalcdep.2014.09.059","article-title":"Substance use and mental health consequences of childhood trauma: An epidemiological investigation","volume":"146","author":"Barrett","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209601_bb0070","article-title":"Prazosin","author":"Basquez","year":"2024"},{"key":"10.1016\/j.josat.2024.209601_bb0075","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/acer.12496","article-title":"Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: A randomized controlled pilot trial","volume":"38","author":"Batki","year":"2014","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1037\/1064-1297.13.3.219","article-title":"Immediate antecedents of cigarette smoking in smokers with and without posttraumatic stress disorder: A preliminary study","volume":"13","author":"Beckham","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0085","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/14622200802123302","article-title":"Ad lib smoking in post-traumatic stress disorder: An electronic diary study","volume":"10","author":"Beckham","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.josat.2024.209601_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1037\/adb0000355","article-title":"Alcohol, cannabis, and other drug use: Engagement and outcome in PTSD treatment","volume":"32","author":"Bedard-Gilligan","year":"2018","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.josat.2024.209601_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.drugalcdep.2013.04.016","article-title":"Comorbidity of posttraumatic stress disorder with alcohol dependence among US adults: Results from national epidemiological survey on alcohol and related conditions","volume":"132","author":"Blanco","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2024.209601_bb0100","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/acer.14649","article-title":"Potential causal effect of posttraumatic stress disorder on alcohol use disorder and alcohol consumption in individuals of European descent: A Mendelian Randomization Study","volume":"45","author":"Bountress","year":"2021","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/15504263.2014.989653","article-title":"PTSD and substance use disorder among veterans: Characteristics, service utilization and pharmacotherapy","volume":"11","author":"Bowe","year":"2015","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/j.josat.2024.209601_bb0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40263-022-00907-3","article-title":"The potential of N-acetyl-L-cysteine (NAC) in the treatment of psychiatric disorders","volume":"36","author":"Bradlow","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.josat.2024.209601_bb0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.ALC.0000156129.98265.57","article-title":"Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder","volume":"29","author":"Brady","year":"2005","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0120","first-page":"502","article-title":"Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence","volume":"56","author":"Brady","year":"1995","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2010.09.007","article-title":"Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse","volume":"129","author":"Breese","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.josat.2024.209601_bb0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-010-2144-9","article-title":"The effect of nicotine and trauma context on acoustic startle in smokers with and without posttraumatic stress disorder","volume":"215","author":"Calhoun","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0145","first-page":"392","article-title":"NLRP3 inflammasome: A new target in psychiatric disorders","volume":"2","author":"\u00c7elik","year":"2021","journal-title":"Journal of Experimental and Basic Medical Sciences"},{"key":"10.1016\/j.josat.2024.209601_bb0155","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/ijms21031103","article-title":"Inflammasome and cognitive symptoms in human diseases: Biological evidence from experimental research","volume":"21","author":"Cheon","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.josat.2024.209601_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0376-8716(01)00157-0","article-title":"Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence","volume":"65","author":"Coffey","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209601_bb0180","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2165\/11203680-000000000-00000","article-title":"Aprepitant: A review of its use in the prevention of nausea and vomiting","volume":"69","author":"Curran","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.josat.2024.209601_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.suponc.2012.05.002","article-title":"Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","volume":"10","author":"Davis","year":"2012","journal-title":"The Journal of Supportive Oncology"},{"key":"10.1016\/j.josat.2024.209601_bb0190","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/15504263.2018.1468947","article-title":"A randomized clinical trial of nicotine preloading for smoking cessation in people with posttraumatic stress disorder","volume":"14","author":"Dedert","year":"2018","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/j.josat.2024.209601_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jad.2010.11.023","article-title":"Full and partial PTSD among young adult survivors 10 months after the L\u2019Aquila 2009 earthquake: Gender differences","volume":"131","author":"Dell\u2019Osso","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.josat.2024.209601_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addbeh.2016.03.004","article-title":"Supplemental nicotine preloading for smoking cessation in posttraumatic stress disorder: Results from a randomized controlled trial","volume":"59","author":"Dennis","year":"2016","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2024.209601_bb0205","author":"Department of Veterans Affairs"},{"key":"10.1016\/j.josat.2024.209601_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/19371918.2013.759031","article-title":"Medications for substance use disorders","volume":"28","author":"Douaihy","year":"2013","journal-title":"Social Work in Public Health"},{"key":"10.1016\/j.josat.2024.209601_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1530-0277.2007.00591.x","article-title":"Trauma and PTSD in patients with alcohol, drug, or dual dependence: A multi-center study","volume":"32","author":"Driessen","year":"2008","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1037\/pha0000232","article-title":"Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder","volume":"27","author":"Flanagan","year":"2019","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11920-016-0709-y","article-title":"Concurrent treatment of substance use and PTSD","volume":"18","author":"Flanagan","year":"2016","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.josat.2024.209601_bb0235","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2013.8268","article-title":"Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: A randomized clinical trial","volume":"310","author":"Foa","year":"2013","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.josat.2024.209601_bb0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1037\/pst0000231","article-title":"A guide to guidelines for the treatment of posttraumatic stress disorder in adults: An update","volume":"56","author":"Hamblen","year":"2019","journal-title":"Psychotherapy"},{"issue":"5","key":"10.1016\/j.josat.2024.209601_bb0255","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"2018","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2024.209601_bb0260","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jts.22521","article-title":"A systematic review of the self-medication hypothesis in the context of posttraumatic stress disorder and comorbid problematic alcohol use","volume":"33","author":"Hawn","year":"2020","journal-title":"Journal of Traumatic Stress"},{"key":"10.1016\/j.josat.2024.209601_bb0265","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1037\/a0038719","article-title":"Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial","volume":"83","author":"Hien","year":"2015","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.josat.2024.209601_bb0270","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neubiorev.2021.05.022","article-title":"A unifying translational framework to advance treatment research for comorbid PTSD and substance use disorders","volume":"127","author":"Hien","year":"2021","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/j.josat.2024.209601_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1176\/appi.ajp.22010071","article-title":"Project harmony: A meta-analysis with individual patient data on behavioral and pharmacologic trials for comorbid posttraumatic stress and alcohol or other drug use disorders","volume":"180","author":"Hien","year":"2023","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0280","series-title":"UpToDate","article-title":"Alcohol use disorder: Pharmacologic management","author":"Holt","year":"2023"},{"key":"10.1016\/j.josat.2024.209601_bb0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15504263.2022.2123119","article-title":"Changes in alcohol consumption following direct-acting antiviral treatment for hepatitis C in VA patients with comorbid alcohol use disorder and PTSD","volume":"18","author":"Hoyt","year":"2022","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/j.josat.2024.209601_bb0290","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00213-020-05548-2","article-title":"Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: A longitudinal pooled analysis of six phase 2 trials","volume":"237","author":"Jerome","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brat.2016.02.001","article-title":"The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving","volume":"79","author":"Kaczkurkin","year":"2016","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.josat.2024.209601_bb0300","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mp.2011.46","article-title":"New medications for drug addiction hiding in glutamatergic neuroplasticity","volume":"16","author":"Kalivas","year":"2011","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.genhosppsych.2015.10.007","article-title":"Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: A systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"Khachatryan","year":"2016","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0310","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/10826084.2023.2170183","article-title":"Predictors of treatment completion among women receiving integrated treatment for comorbid posttraumatic stress and substance use disorders","volume":"58","author":"Killeen","year":"2023","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2024.209601_bb0315","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/dar.12448","article-title":"A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia","volume":"36","author":"Kingston","year":"2017","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2024.209601_bb0320","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2024.209601_bb0330","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-014-3665-4","article-title":"The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: A human experimental study","volume":"232","author":"Kwako","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(07)67011-3","article-title":"The functional neuroanatomy of PTSD: A critical review","volume":"167","author":"Liberzon","year":"2008","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.josat.2024.209601_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.etdah.2021.100017","article-title":"Pharmacological assistance for psychotherapy","volume":"1","author":"Lochtenberg","year":"2021","journal-title":"Emerging Trends in Drugs, Addictions, and Health"},{"key":"10.1016\/j.josat.2024.209601_bb0345","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuropharm.2011.07.007","article-title":"Stress modulation of drug self-administration: Implications for addiction comorbidity with post-traumatic stress disorder","volume":"62","author":"Logrip","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0350","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.12998\/wjcc.v7.i24.4254","article-title":"Chronic pain, posttraumatic stress disorder, and opioid intake: A systematic review","volume":"7","author":"L\u00f3pez-Mart\u00ednez","year":"2019","journal-title":"World Journal of Clinical Cases"},{"key":"10.1016\/j.josat.2024.209601_bb0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnbeh.2020.00006","article-title":"Mechanisms of shared vulnerability to post-traumatic stress disorder and substance use disorders","volume":"14","author":"Mar\u00eda-R\u00edos","year":"2020","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.josat.2024.209601_bb0360","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/add.12943","article-title":"A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder","volume":"110","author":"McGovern","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2024.209601_bb0365","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.janxdis.2014.09.023","article-title":"Posttraumatic stress disorder and alcohol dependence: Does order of onset make a difference?","volume":"28","author":"McLean","year":"2014","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.josat.2024.209601_bb0370","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1037\/ccp0000024","article-title":"Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence","volume":"83","author":"McLean","year":"2015","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.josat.2024.209601_bb0375","doi-asserted-by":"crossref","first-page":"893","DOI":"10.5665\/sleep.3654","article-title":"Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality","volume":"37","author":"Meyerhoff","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.josat.2024.209601_bb0380","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nature Medicine"},{"key":"10.1016\/j.josat.2024.209601_bb0385","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nature Medicine"},{"key":"10.1016\/j.josat.2024.209601_bb0390","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cpr.2016.09.001","article-title":"Cortisol, heart rate, and blood pressure as early markers of PTSD risk: A systematic review and meta-analysis","volume":"49","author":"Morris","year":"2016","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.josat.2024.209601_bb0395","article-title":"Depression and\/or PTSD comorbidity affects response to antidepressants in those with alcohol use disorder","volume":"12","author":"Na","year":"2021","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0400","author":"NICE"},{"key":"10.1016\/j.josat.2024.209601_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109356","article-title":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","volume":"233","author":"Nicholas","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209601_bb0410","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2007.03.002","article-title":"Do trauma history and PTSD symptoms influence addiction relapse context?","volume":"90","author":"Norman","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2024.209601_bb0415","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamapsychiatry.2019.0638","article-title":"Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder","volume":"76","author":"Norman","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0420","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pscychresns.2014.09.004","article-title":"A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder","volume":"224","author":"Pennington","year":"2014","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.josat.2024.209601_bb0425","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/acer.12926","article-title":"Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: A clinical trial","volume":"40","author":"Petrakis","year":"2016","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0430","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2006.03.074","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder","volume":"60","author":"Petrakis","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0435","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/npp.2011.283","article-title":"Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence","volume":"37","author":"Petrakis","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0440","author":"Phoenix Australia"},{"key":"10.1016\/j.josat.2024.209601_bb0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/gbb.12187","article-title":"Epigenetics and memory: Causes, consequences and treatments for post-traumatic stress disorder and addiction","volume":"14","author":"Pizzimenti","year":"2015","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/j.josat.2024.209601_bb0455","author":"RANZCP"},{"key":"10.1016\/j.josat.2024.209601_bb0460","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1507598","article-title":"Trial of prazosin for post-traumatic stress disorder in military veterans","volume":"378","author":"Raskind","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2024.209601_bb0465","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","article-title":"A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan","volume":"170","author":"Raskind","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0470","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ajad.12292","article-title":"The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders","volume":"24","author":"Saunders","year":"2015","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.josat.2024.209601_bb0475","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00213-013-3430-0","article-title":"An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation","volume":"231","author":"Sch\u00fcz","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209601_bb0480","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4088\/JCP.15m09893","article-title":"Observational evidence for buprenorphine\u2019s impact on posttraumatic stress symptoms in veterans with chronic pain and opioid use disorder","volume":"77","author":"Seal","year":"2016","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2024.209601_bb0485","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1037\/adb0000568","article-title":"Shared molecular genetic risk of alcohol dependence and posttraumatic stress disorder (PTSD)","volume":"34","author":"Sheerin","year":"2021","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.josat.2024.209601_bb0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jad.2019.01.037","article-title":"Reduced gamma-amino butyric acid (GABA) and glutamine in the anterior cingulate cortex (ACC) of veterans exposed to trauma","volume":"248","author":"Sheth","year":"2019","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.josat.2024.209601_bb0495","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2021.10.008","article-title":"Mining clinical data for novel posttraumatic stress disorder medications","volume":"91","author":"Shiner","year":"2022","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0500","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/aje\/kwac104","article-title":"Comparative effectiveness of direct-acting antivirals for posttraumatic stress disorder in veterans affairs patients with hepatitis C virus infection","volume":"191","author":"Shiner","year":"2022","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.josat.2024.209601_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2021.102490","article-title":"Efficacy and acceptability of interventions for co-occurring PTSD and SUD: A meta-analysis","volume":"84","author":"Simpson","year":"2021","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.josat.2024.209601_bb0510","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/acer.12703","article-title":"A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder","volume":"39","author":"Simpson","year":"2015","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0515","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/add.14565","article-title":"Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: Findings from NESARC-III","volume":"114","author":"Simpson","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2024.209601_bb0520","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archgenpsychiatry.2011.49","article-title":"Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes","volume":"68","author":"Sinha","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.josat.2024.209601_bb0525","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0376-8716(00)00199-X","article-title":"Depressive symptoms modulate the subjective and physiological response to cocaine in humans","volume":"63","author":"Sofuoglu","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209601_bb0530","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0376-8716(02)00328-9","article-title":"Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine","volume":"69","author":"Sofuoglu","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209601_bb0535","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addbeh.2013.08.014","article-title":"Pharmacological treatment of comorbid PTSD and substance use disorder: Recent progress","volume":"39","author":"Sofuoglu","year":"2014","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2024.209601_bb0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psyneuen.2015.05.007","article-title":"Hair cortisol concentrations and cortisol stress reactivity predict PTSD symptom increase after trauma exposure during military deployment","volume":"59","author":"Steudte-Schmiedgen","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.josat.2024.209601_bb0545","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2006.11.006","article-title":"Health problems of substance-dependent veterans with and those without trauma history","volume":"33","author":"Tate","year":"2007","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2024.209601_bb0550","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/acer.13969","article-title":"Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder","volume":"43","author":"Verplaetse","year":"2019","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.josat.2024.209601_bb0555","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.copsyc.2016.11.004","article-title":"Reward functioning in posttraumatic stress and substance use disorders","volume":"14","author":"Vujanovic","year":"2017","journal-title":"Current Opinion in Psychology"},{"key":"10.1016\/j.josat.2024.209601_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1037\/ccp0000052","article-title":"Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome","volume":"84","author":"Zandberg","year":"2016","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.josat.2024.209601_bb0570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1176\/appi.ajp.2018.17090995","article-title":"Doubly randomized preference trial of prolonged exposure versus sertraline for treatment of PTSD","volume":"176","author":"Zoellner","year":"2019","journal-title":"American Journal of Psychiatry"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924003138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924003138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T17:27:12Z","timestamp":1739208432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924003138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":101,"alternative-id":["S2949875924003138"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209601","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatments for co-occurring PTSD and substance use disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209601"}}